NCT06961214: Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- State
- Under way
- Phase
- Phase 3
- People
- 961 planned
- Started
- 23 Jun 2025
- Primary completion
- 13 Dec 2028
- Arms
- Depemokimab
- Results
- None posted
- 7 May 2025: Trial registered
- 23 Jun 2025: Trial started